The Indian government may be looking to put pressure on Serum to lower its prices, as seen by its controversial decision to greenlight a rival vaccine
Bharat Biotech is currently working on two intra-nasal vaccines
Health personnel succh as doctors and nurses and frontline workers such as police personnel, home guards won't have to register themselves online to get the vaccine
Adar Poonawalla and Krishna Ella issue joint statement saying they would work together to roll out Covid-19 vaccine
Minutes of expert panel meeting made public
A FinMin report says India is witnessing a 'V-shaped' economic recovery since June; China court awards death sentence to former business executive.
The more important task right now is of saving the lives and livelihoods of populations in India and around the world, a joint statement by both companies said
Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19
The media and opposition figures have justifiably asked why Bharat Biotech's candidate was approved at the same time as AstraZeneca's, when it hasn't even finished or published results from Stage III
Here's a selection of Business Standard opinion pieces for the day
I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says
Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine
Approval to Covaxin raises many questions
The hasty nod for Bharat Biotech's Covaxin, developed in collaboration with the ICMR and National Institute of Virology, has raised eyebrows in the scientific and healthcare communities
Lauding the people behind this Made in India initiative, Modi said: "The country is proud of the contributions of its scientists and technicians."
The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday
Questions were raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine without publication of efficacy data
Bharat Biotech on Monday said the firm is setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum
How was the nationwide dry run carried out, the next steps in the vaccine roll-out, findings from a large-scale UK study on the new variant, and more-news relevant to India's fight against Covid-19
Health Minister Harsh Vardhan termed it a 'watershed moment in India's battle against Covid-19'